NDX
Home
Browse All Titles
Sign In
GoogleAnalytics
Browse All Titles
Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002?IndexTerms-page=1
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
View All
IAP
ICOS
IDH1
IHC
IL-2
immune-related adverse effects (irAEs)
immunomodulatory drugs (IMiDs)
Immunotherapeutics
CD8+ T effector cells
signaling network
anti-pD-1 and anti-pD-l1
characteristics
IMPDH
inducible T-cell costimulator (ICOS)
infusion-related reaction (IRR)
Question 12.3
Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
inosine-5'-monophosphate (IMP)
interferon (IFN)
Answer 12.5
Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents
interferon regulatory factor 4 (IRF4)
interleukin-2 (IL-2)
Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents
Transplant-Related Agents
Question 12.5
intermittent and rogen deprivation (IAD)
Male Hormonal Therapies
Answer 10.2
intrathecal (IT)
intravenous (IV)
Question 3.6
Question 3.2
irAEs
IRR
isocitrate dehydrogenase 1 (IDH1)
IV
IAD
ICL
IDH
IFN
IL
IMiDs
immunohistochemistry (IHC)
IMP
Refresh
first
prev
1
2
30
select
next
last
Displaying items 1 - 30 of 39